GLAXOSMITHKLINE BIOLOGICALS MANUFACTURING S.A.

HERPEVAC

Vaccines for human use;

MAGERION

human vaccines;

MAGESS

HUMAN VACCINES;

NASTIL

In the statement, column 2, line 16, REG. DATE 1-24-2005 should be deleted, and, REG. DATE 2-5-2003 should be inserted. In the statement, column 2, line 17, EXPIRATION DATE 3-13-2013 should be deleted, and, EXPIRATION DATE 2-5-2013 should be inserted. In the statement, column 2, after line 17, OWNER IF ERPN CMNTY TM OFC REG. NO. 003095205, DATED 1-24-2005, EXPIRES 3-13-2013 should be inserted.;machines and apparatus for use in sterile filling, including for sterile filling in the pharmaceutical industry, namely isolators and isolation barriers;packaging services, namely, sterile packaging of articles for transportation in the pharmaceutical and medical industries; providing information relating to the sterile packaging of articles for transportation in the pharmaceutical and medical industries;cleaning of machines and apparatus for use in sterile filling, including for sterile filling in the pharmaceutical industry, namely isolators and isolation barriers;sterilizers not for medical purposes;scientific and technical consultation and research in the field of sterile packaging and filling in the pharmaceutical and medical industries;

NOSOTEQ

monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus;

STAPHBREAK

monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus; monoclonal antibodies for the treatment of low birth weight babies, susceptible to bacterial infections, in particular Staphylococcal epidermidis and Staphylococcal aureus;STAPHYLOCOCCAL BREAK;